These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 26571395)
1. Inflammation drives thrombosis after Salmonella infection via CLEC-2 on platelets. Hitchcock JR; Cook CN; Bobat S; Ross EA; Flores-Langarica A; Lowe KL; Khan M; Dominguez-Medina CC; Lax S; Carvalho-Gaspar M; Hubscher S; Rainger GE; Cobbold M; Buckley CD; Mitchell TJ; Mitchell A; Jones ND; Van Rooijen N; Kirchhofer D; Henderson IR; Adams DH; Watson SP; Cunningham AF J Clin Invest; 2015 Dec; 125(12):4429-46. PubMed ID: 26571395 [TBL] [Abstract][Full Text] [Related]
2. Physiologic and pathophysiologic roles of interaction between C-type lectin-like receptor 2 and podoplanin: partners from in utero to adulthood. Suzuki-Inoue K; Osada M; Ozaki Y J Thromb Haemost; 2017 Feb; 15(2):219-229. PubMed ID: 27960039 [TBL] [Abstract][Full Text] [Related]
3. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. Suzuki-Inoue K Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548 [TBL] [Abstract][Full Text] [Related]
4. Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis. Payne H; Ponomaryov T; Watson SP; Brill A Blood; 2017 Apr; 129(14):2013-2020. PubMed ID: 28104688 [TBL] [Abstract][Full Text] [Related]
5. C-type lectin-like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor-bearing mice. Shirai T; Inoue O; Tamura S; Tsukiji N; Sasaki T; Endo H; Satoh K; Osada M; Sato-Uchida H; Fujii H; Ozaki Y; Suzuki-Inoue K J Thromb Haemost; 2017 Mar; 15(3):513-525. PubMed ID: 28028907 [TBL] [Abstract][Full Text] [Related]
6. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin. Suzuki-Inoue K Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):175-181. PubMed ID: 31808911 [TBL] [Abstract][Full Text] [Related]
7. CEACAM2 negatively regulates hemi (ITAM-bearing) GPVI and CLEC-2 pathways and thrombus growth in vitro and in vivo. Alshahrani MM; Yang E; Yip J; Ghanem SS; Abdallah SL; deAngelis AM; O'Malley CJ; Moheimani F; Najjar SM; Jackson DE Blood; 2014 Oct; 124(15):2431-41. PubMed ID: 25085348 [TBL] [Abstract][Full Text] [Related]
11. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets. Suzuki-Inoue K; Inoue O; Ding G; Nishimura S; Hokamura K; Eto K; Kashiwagi H; Tomiyama Y; Yatomi Y; Umemura K; Shin Y; Hirashima M; Ozaki Y J Biol Chem; 2010 Aug; 285(32):24494-507. PubMed ID: 20525685 [TBL] [Abstract][Full Text] [Related]
12. Platelet glycoprotein VI and C-type lectin-like receptor 2 deficiency accelerates wound healing by impairing vascular integrity in mice. Wichaiyo S; Lax S; Montague SJ; Li Z; Grygielska B; Pike JA; Haining EJ; Brill A; Watson SP; Rayes J Haematologica; 2019 Aug; 104(8):1648-1660. PubMed ID: 30733265 [TBL] [Abstract][Full Text] [Related]
13. Significant Hypo-Responsiveness to GPVI and CLEC-2 Agonists in Pre-Term and Full-Term Neonatal Platelets and following Immune Thrombocytopenia. Hardy AT; Palma-Barqueros V; Watson SK; Malcor JD; Eble JA; Gardiner EE; Blanco JE; Guijarro-Campillo R; Delgado JL; Lozano ML; Teruel-Montoya R; Vicente V; Watson SP; Rivera J; Ferrer-Marín F Thromb Haemost; 2018 Jun; 118(6):1009-1020. PubMed ID: 29695020 [TBL] [Abstract][Full Text] [Related]
14. CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis. May F; Hagedorn I; Pleines I; Bender M; Vögtle T; Eble J; Elvers M; Nieswandt B Blood; 2009 Oct; 114(16):3464-72. PubMed ID: 19641185 [TBL] [Abstract][Full Text] [Related]
15. The podoplanin-CLEC-2 axis inhibits inflammation in sepsis. Rayes J; Lax S; Wichaiyo S; Watson SK; Di Y; Lombard S; Grygielska B; Smith SW; Skordilis K; Watson SP Nat Commun; 2017 Dec; 8(1):2239. PubMed ID: 29269852 [TBL] [Abstract][Full Text] [Related]
18. Phosphorylation on Syk Y342 is important for both ITAM and hemITAM signaling in platelets. Kostyak JC; Mauri B; Dangelmaier C; Vari HR; Patel A; Wright M; Reddy H; Tsygankov AY; Kunapuli SP J Biol Chem; 2022 Aug; 298(8):102189. PubMed ID: 35753354 [TBL] [Abstract][Full Text] [Related]
19. CLEC-2-dependent platelet subendothelial accumulation by flow disturbance contributes to atherogenesis in mice. Tang C; Wang L; Sheng Y; Zheng Z; Xie Z; Wu F; You T; Ren L; Xia L; Ruan C; Zhu L Theranostics; 2021; 11(20):9791-9804. PubMed ID: 34815786 [No Abstract] [Full Text] [Related]
20. G6b-B inhibits constitutive and agonist-induced signaling by glycoprotein VI and CLEC-2. Mori J; Pearce AC; Spalton JC; Grygielska B; Eble JA; Tomlinson MG; Senis YA; Watson SP J Biol Chem; 2008 Dec; 283(51):35419-27. PubMed ID: 18955485 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]